Renaissance Capital logo

HLI News

US IPO Week Ahead: The IPO market takes a breather in a 4 IPO week

BEKE

Updated Monday, 8/10 After an active July, the US IPO market is taking a breather. Three companies are scheduled to raise $2.5 billion in the week ahead, led by Chinese real estate giant KE Holdings (BEKE). KE Holdings (BEKE), China's largest housing platform operating under the Lianjia and Beike brands, plans to raise $1.9 billion at a $20.7...read more

US IPO Weekly Recap: Sickle cell biotech pops 100% and investment bank goes public

GBT

Global Blood Therapeutics became the fifth IPO of 2015 to pop more than 100% on its first day. Year-to-date, 130 IPOs have raised $22 billion, or 31% fewer IPOs than last year and 45% less capital. Even with six postponements this month, ...read more

Investment bank Houlihan Lokey prices downsized IPO below the range at $21

HLI

Houlihan Lokey, a leading mid-cap focused independent investment bank, raised $221 million by offering 10.5 million shares at $21, below the range of $22 to $24. Selling shareholders floated the entire IPO. Houlihan had originally planned to raise $300 million by offering 13.1 million shares Houlihan Lokey plans to list on the NYSE under the symbol HLI. BofA Merrill...read more

Week ahead: 5 IPOs set to price during the week of August 10

HLI

It's the final push for US IPOs before a four-week lull that should end in mid-September. Five IPOs are on the calendar this week, plus two blank check companies. Sickle cell biotech Global Blood Therapeutics could attract investor attention, while investment bank Houlihan Lokey boasts a...read more